歐普康視(300595.SZ):擬合計約5.06億元收購福州歐普、蘇州康視等13家公司部分股權
格隆匯6月19日丨歐普康視(300595.SZ)公佈,公司擬以現金收購13家控股子/孫公司部分股東權益。收購完成後,歐普康視將單獨或與下屬子公司合計持有該等控股子/孫公司90%的股權,交易對方仍繼續持有10%的股權。交易對方承諾並保證本次股權轉讓價款的75%將全部用於在二級市場購買歐普康視股票,將與歐普康視繼續保持長期合作關係。
2023年6月16日,歐普康視與交易對方簽署《股權轉讓協議》,擬以現金收購葉曉丹、廖聯明、羅東明合計持有的福州歐普康視醫療器械有限公司(簡稱“福州歐普”)39%股權,收購袁莉莉、孫惟玲合計持有的蘇州市康視健康用眼信息諮詢有限公司(簡稱“蘇州康視”)39%股權,收購莊朝陽、鄭晶合計持有的泉州歐普康視光學技術有限公司(簡稱“泉州歐普”)39%股權,收購侯愛華、陸漢興合計持有的靖江歐普睛呈眼健康服務有限公司(簡稱“靖江歐普”)39%股權,收購張明靜、歐陽忠華、雲南視理康企業管理合夥企業(有限合夥)合計持有的昆明視康眼科診所有限公司(簡稱“昆明視康”)39%股權,收購石靜持有的蚌埠歐普康視光學設備科技有限公司(簡稱“蚌埠歐普”)39%股權,收購趙曉婷、李憲亭合計持有的深圳明眸瑞視眼科診所(簡稱“深圳明眸”)39%股權,收購黃朝暉、何小清合計持有的宣城市口腔醫院有限公司(簡稱“宣城口腔醫院”)39%股權,收購王鐵漢持有的仙桃市佳視眼科門診有限公司(簡稱“仙桃佳視”)39%股權,收購劉宗珍、柳紅合計持有的宜昌夢戴維視光科技有限責任公司(簡稱“宜昌夢戴維”)39%股權,收購黃嚴渝路、胡晨穎合計持有的宣城市夢戴維醫療器械有限公司(簡稱“宣城夢戴維”)39%股權,收購胡煒、蕪湖歐普康視視力健康諮詢合夥企業(有限合夥)合計持有的蕪湖歐普康視醫療器械銷售有限公司(簡稱“蕪湖歐普”)合計20%股權,收購黃廣祿、劉繼華合計持有的宣城市歐普康視百秀醫療器械有限公司(簡稱“宣城歐普百秀”)30%股權。
本次收購的上述標的公司已形成良好的發展基礎,根據上述標的公司的資產評估報吿及現有的業務、人才和技術的基本情況,經交易各方協商一致,福州歐普39%的股權交易價格為116,580,686元,蘇州康視39%的股權交易價格為107,306,035元,泉州歐普39%的股權交易價格為30,030,302元,靖江歐普39%的股權交易價格為21,508,532元,昆明視康39%的股權交易價格為58,145,001元,蚌埠歐普39%的股權交易價格為45,006,452元,深圳明眸39%的股權交易價格為20,681,923元,宣城口腔醫院39%的股權交易價格為16,263,597元,仙桃佳視39%的股權交易價格為17,417,573元,宜昌夢戴維39%的股權交易價格為20,358,085元,宣城夢戴維39%的股權交易價格為21,158,245元,蕪湖歐普20%的股權交易價格為9,620,000元,宣城歐普百秀30%的股權交易價格為21,930,000元。交易對價合計約5.06億元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.